Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Acute kidney injury
How do you evaluate for clinically significant ureteral obstruction in a pregnant patient with AKI, since physiological hydronephrosis on kidney ultrasound is common?
Related Questions
Do you avoid terlipressin for patients with hepatorenal syndrome who have a serum sodium level less than 125 mEq/L?
Would you add regional citrate anticoagulation to a CRRT prescription for a patient on systemic heparin but who experiences recurrent filter clotting?
In which clinical scenarios do you use prolonged intermittent renal replacement therapy (PIRRT)?
Do you use PTH levels to help differentiate CKD from AKI in patients who are being evaluated for an elevated creatinine level and who lack long term lab data?
Do you recommend any CRRT prescription changes for optimal clearance for patients with AKI who are on a reduced blood flow rate due to concurrent regional citrate anticoagulation?
How do you approach the workup of a patient with a large focal wedge-shaped cortical swelling on CT concerning for renal infarct, but with a normal echocardiogram showing no thrombus or vegetation?
Do you check a fractional excretion of sodium in nonoliguric patients with AKI?
Would you recommend administering IV amino acids prior to cardiac surgery with cardiopulmonary bypass, given recent trial findings of improved AKI rates but no significant difference in kidney-replacement therapy with IV amino acids?
Do you recommend avoiding combination vancomycin and piperacillin-tazobactam in patients with acute kidney injury?
Do you target specific Kt/V values or specific duration of hemodialysis sessions for hospitalized patients who you are planning several consecutive and progressive hemodialysis initiation sessions?
